Last week’s expiry of the patent for semaglutide—the active ingredient in Novo Nordisk’s blockbuster drugs Wegovy and Ozmepic that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions by some of India’s biggest pharma companies.
Huawei-backed Yuanjie Semiconductor Technology makes photonic chips used in optical interconnects in AI data centers.
The Chinese gaming and social media giant has ample resources to pour into AI. During the final three months of last year, revenues grew 13% year-on-year to 194.4 billion yuan ($28 billion).
The Christmas Eve agreement—billed as Nvidia’s biggest deal in its three-decade history—landed at a precarious moment for Groq. Now Nvidia is betting on Groq’s inference-speed tech inside a newly announced chip platform.
The company that supplies New York City’s bus cameras has sued its CEO Chris Carson, alleging he forged signatures to secretly sell part of his stake. He apparently spent the money on fancy cars and a $2.7 million home in Boca Raton, Florida.
Many billionaires have kowtowed to the President lately. That’s what makes Dario Amodei’s refusal to cave so stunning — and may be behind Claude’s surge at the App Store.
Sunway Healthcare—controlled by Malaysian billionaire Jeffrey Cheah’s Sunway Group—will use proceeds from the IPO to partly finance expansion plans, which include building three new hospitals.
The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.
Despite digs from Sam Altman and Elon Musk, Anthropic is on a hot streak thanks to a 20,000-word essay, a memorable Super Bowl ad campaign and a $30 billion fundraise.
Applied Intuition’s cofounders are building software that can drive everything from planes to tanks to automobiles. But to expand beyond its $800 million business selling tech for cars, they will have to take on Tesla, Google, Nvidia and a host of othe…